These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 18158992

  • 1. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
    Xiong SL, Wang Q, Zheng L, Li JL, Wen ZB, He SL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
    [Abstract] [Full Text] [Related]

  • 2. [Observation on tissue factor pathway during the onset of acute cerebral infarction].
    Wen ZB, Xiong SL, He XF, He MX, He SL, Xie QZ, Jian ZF, Chen FP, Xiao B, Yang QD.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Sep; 15(9):529-31. PubMed ID: 12971845
    [Abstract] [Full Text] [Related]

  • 3. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
    Wang R, Wen BZ, Ma YT, Peng -, Li H, Zhong D, Li L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
    [Abstract] [Full Text] [Related]

  • 4. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
    Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, Prisco D, Pepe G, Abbate R, Gensini GF, Neri Serneri GG.
    Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
    [Abstract] [Full Text] [Related]

  • 5. [Plasma tissue factor and tissue factor pathway inhibitor levels in acute myocardial infarction patients with no-reflow during percutaneous coronary intervention].
    Xu P, Qi XY, Li CH, Zhang JH, Liu DM, Liu J, Wang WL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Nov; 36(11):1013-5. PubMed ID: 19102916
    [Abstract] [Full Text] [Related]

  • 6. [Levels of plasma TF and TFPI activities in patients with acute leukemia].
    Zhu Y, Xie ZX, He XF, Han JZ, Li JC, He SL.
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug 28; 25(4):401-2, 405. PubMed ID: 12206017
    [Abstract] [Full Text] [Related]

  • 7. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B, Borawski J, Chyczewski L, Pawlak K, Mysliwiec M.
    Nephrol Dial Transplant; 2006 Dec 28; 21(12):3450-7. PubMed ID: 16982632
    [Abstract] [Full Text] [Related]

  • 8. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M, Abe S, Ogawa M, Yamashita T, Biro S, Minagoe S, Maruyama I, Tei C.
    Thromb Haemost; 2001 Nov 28; 86(5):1197-203. PubMed ID: 11816707
    [Abstract] [Full Text] [Related]

  • 9. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
    Lizakowski S, Zdrojewski Z, Jagodzinski P, Rutkowski B.
    Scand J Urol Nephrol; 2007 Nov 28; 41(3):237-42. PubMed ID: 17469034
    [Abstract] [Full Text] [Related]

  • 10. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients.
    Teng Y, Jiang R, Lin Q, Ding C, Ye Z.
    Thromb Res; 2010 Jul 28; 126(1):e41-5. PubMed ID: 20226500
    [Abstract] [Full Text] [Related]

  • 11. Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events.
    Campo G, Valgimigli M, Ferraresi P, Malagutti P, Baroni M, Arcozzi C, Gemmati D, Percoco G, Parrinello G, Ferrari R, Bernardi F.
    Arterioscler Thromb Vasc Biol; 2006 Dec 28; 26(12):2800-6. PubMed ID: 17008590
    [Abstract] [Full Text] [Related]

  • 12. The relation between plasma tissue factor and oxidized LDL levels in acute coronary syndromes.
    Emekli-Alturfan E, Basar I, Alturfan AA, Ayan F, Koldas L, Balci H, Emekli N.
    Pathophysiol Haemost Thromb; 2007 Dec 28; 36(6):290-7. PubMed ID: 20224254
    [Abstract] [Full Text] [Related]

  • 13. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
    Gosk-Bierska I, Wysokin Ski W, Karnicki K, Adamiec R.
    Int Angiol; 2008 Aug 28; 27(4):296-301. PubMed ID: 18677291
    [Abstract] [Full Text] [Related]

  • 14. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
    Shimura M, Wada H, Wakita Y, Nakase T, Hiyoyama K, Nagaya S, Mori Y, Shiku H.
    Am J Hematol; 1996 Jul 28; 52(3):165-70. PubMed ID: 8756081
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M, Ranlall N, Patel G, Rutlin A, Jehanli A, Kakkar VV.
    Blood Coagul Fibrinolysis; 2000 Apr 28; 11(3):285-91. PubMed ID: 10870809
    [Abstract] [Full Text] [Related]

  • 16. Impact of long-term testosterone treatment on plasma levels of free TFPI and TF-induced thrombin generation ex vivo in elderly men with low testosterone levels.
    Agledahl I, Brodin E, Svartberg J, Hansen JB.
    Thromb Haemost; 2009 Nov 28; 102(5):945-50. PubMed ID: 19888533
    [Abstract] [Full Text] [Related]

  • 17. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M, Wada H, Wakita Y, Shimura M, Nakase T, Hiyoyama K, Nagaya S, Minami N, Nakano T, Shiku H.
    Thromb Haemost; 1995 Jan 28; 73(1):10-4. PubMed ID: 7740478
    [Abstract] [Full Text] [Related]

  • 18. Detection of circulating tissue factor and factor VII in a normal population.
    Albrecht S, Kotzsch M, Siegert G, Luther T, Grossmann H, Grosser M, Müller M.
    Thromb Haemost; 1996 May 28; 75(5):772-7. PubMed ID: 8725722
    [Abstract] [Full Text] [Related]

  • 19. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
    Moor E, Hamsten A, Karpe F, Båvenholm P, Blombäck M, Silveira A.
    Thromb Haemost; 1994 Jun 28; 71(6):707-12. PubMed ID: 7974336
    [Abstract] [Full Text] [Related]

  • 20. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
    Kario K, Matsuo T, Asada R, Sakata T, Kato H, Miyata T.
    Thromb Haemost; 1995 Mar 28; 73(3):429-34. PubMed ID: 7667824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.